Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
11/24/14 Actavis (ACT) Tudorza-formoterol for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
11/24/14 Prosensa Holding (RNA) Drisapersen for Muscular Dystrophy Subscribers Only Subscribers Only Subscribers Only
11/21/14 ZS Pharma (ZSPH) ZS-9 for Hyperkalemia Subscribers Only Subscribers Only Subscribers Only
11/21/14 Astellas (4503:JP) Isavuconazole for Fungal Infections - Systemic Subscribers Only Subscribers Only Subscribers Only
11/20/14 Purdue Pharma Hysingla ER for Chronic Pain Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
11/24/14 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 11/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 11/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 11/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 11/25/14 Subscribers Only Subscribers Only Company - Earnings Announcement